Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:27 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 195 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Female Infertility Clear all

Conditions: Infertility, Female
Interventions: sonoHSG; Procedure
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Chorioamnionitis
Interventions: Type of glove used for intrapartum vaginal exams; Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older · Female only
Enrollment: 507 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Infertility
Interventions: Acupuncture; Procedure
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 21 Years to 42 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Infertility, Female
Interventions: Diet Intervention - Group 1, Exercise Intervention - Group 1; Other
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 21 Years and older · Female only
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Infertility, Infertility Secondary, Infertility Unexplained, Anovulation, Fertility Disorders, Reproductive Issues
Interventions: Zymot Multi sperm separation device, Density gradient centrifugation; Device · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Primary Ovarian Insufficiency, Low Ovarian Reserve, Premature Ovarian Failure
Interventions: ROSE-1 Protocol; Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pregnancy Related, Pre-Eclampsia
Interventions: Modified natural cycle, Programmed cycle; Procedure
Lead sponsor: JHSPH Center for Clinical Trials; Other
Eligibility: 18 Years to 41 Years · Female only
Enrollment: 788 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 15
States / cities: San Francisco, California • Sunnyvale, California • Orange, Connecticut + 12 more

Conditions: Infertility
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 1,235 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Infertility
Interventions: In-vitro fertilization using Eeva; Device
Lead sponsor: Progyny, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Encino, California

Conditions: Progesterone Supplementation in Women Undergoing ART
Interventions: Progesterone vaginal ring; Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 34 Years · Female only
Enrollment: 352 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 15
States / cities: Tempe, Arizona • Encino, California • Newark, Delaware + 12 more

Conditions: Infertility, Female, Anxiety
Interventions: Lavender, Water; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Infertility, Female
Interventions: Endometrial biopsy; Other
Lead sponsor: Reproductive Medicine Associates of New Jersey; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Basking Ridge, New Jersey

Conditions: Polycystic Ovary Syndrome, Metabolic Syndrome
Interventions: flutamide, ethinyl estradiol 35 mcg and drospirenone 3 mg, placebo; Drug · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Male Infertility, Unexplained Infertility, Abortion, Habitual
Interventions: Not listed
Lead sponsor: Northwell Health; Other
Eligibility: Male only
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Vaginosis, Bacterial, Infertility, Miscarriage
Interventions: Metronidazole, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Infertility, Female
Interventions: Caloric Restriction, Orlistat, Moderate physical activity; Other · Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 379 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 10
States / cities: San Francisco, California • Augusta, Georgia • Southfield, Michigan + 7 more

Conditions: Anovulation
Interventions: Anastrozole 1 mg, Anastrozole 5 mg, Anastrozole 10 mg, Clomiphene Citrate 50 mg, Clomiphene Citrate 100 mg; Drug
Lead sponsor: EMD Serono; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 271 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Rockland, Massachusetts

Conditions: Mayer Rokitansky Kuster Hauser Syndrome, Absence of Uterus, Infertility of Uterine Origin
Interventions: Uterine Transplant; Other
Lead sponsor: John Goss; Other
Eligibility: 20 Years to 65 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Infertile Females or Females With Ovarian Insufficiency
Interventions: Transplantation of previously cryopreserved ovarian tissu; Procedure
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Infertility, Pregnancy Loss, Spontaneous Abortion
Interventions: Blood Collection; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Infertility
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cervical Cancer, Endometrial Cancer, Leukemia, Non-Hodgkin's Lymphoma, Uterine Cancer, Vaginal Cancer, Infertility
Interventions: survey instrument; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 179 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Infertility, Female
Interventions: G-CSF, Saline; Drug
Lead sponsor: Center for Human Reproduction; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Infertility, Female, Infertility
Interventions: Clomiphene; Drug
Lead sponsor: Neil Chappell; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 10 participants
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Search by objective public record fields.

Safety and Efficacy of Sonohysterosalpingography for the Evaluation of Infertility

Intrapartum Study of Sterile and Clean Gloves

Effect of Acupuncture on Vascular Biomarkers and Psychological Well-Being of Women Undergoing IVF

The MOM TO BE Study

Sperm Preparation Prior to Intrauterine Insemination Study

Rejuvenation of Premature Ovarian Failure With Stem Cells

Natural Versus Programmed Frozen Embryo Transfer (NatPro)

Infertility Markers in Serum, Urine, and Follicular Fluid

Eeva 12-well Dish Study

Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures

Lavender During Intrauterine Insemination

Transcriptomic Evaluation of Endometrial Receptivity

Metabolic Syndrome in PCOS: Precursors and Interventions

Impact of Sperm DNA Integrity on In Vitro Cycles

Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population

Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained Infertility

Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction

Uterine Transplant for Women With Absolute Uterine Factor Infertility (AUFI)

Ovarian Tissue Transplantation

Measuring Immune Tolerance to Predict Miscarriage or Failed Embryo Transfer

Ovarian Stem Cells From Women With Ovarian Insufficiency

Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance

Effect of Colony Stimulating Factor on Poor Endometrial Development During IVF

Use of Clomiphene Citrate as an Inhibitor of Ovulation in an Oocyte Cryopreservation Cycle